34 unknown. 34 Phase 2, 11 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 34 | Unknown 34 |
| Phase 1 | 11 | Unknown 11 |
| Phase 3 | 6 | Unknown 6 |
Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis CU104, Placebo - Ulcerative Colitis | Phase 2 | Unknown | Curacle Co., Ltd. | 45 | 2024-06-01 | 2023-06-18 |
| Unravelling Intestinal Fibrosis in Ulcerative Colitis Fibroblast Activation Protein Inhibitor - Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2024-04-03 | 2024-09-19 |
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 21 | 2024-03-01 | 2024-03-12 |
| FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients 68Ga-FAPi-46 - IBD (Inflammatory Bowel Disease), Crohn Disease (CD) | Phase 2 | Unknown | Dalia Lartey | 20 | 2023-08-31 | 2024-09-19 |
| Saffron and Ulcerative Colitis Saffron 100, Saffron 50, Placebo - Ulcerative Colitis | Phase 2 | Unknown | Shiraz University of Medical Sciences | 60 | 2023-05-01 | 2022-05-11 |
| Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients CBD, synthetic form, Placebo - Ulcerative Colitis | Phase 2 | Unknown | CannaMore Biotechs | 45 | 2023-03-01 | 2024-04-09 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
| Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy Mesenchymal Stromal Cell (MSC) injections - Pelvic Radiation Therapy, Radiation-induced Hemorrhagic Cystitis | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 12 | 2021-04-14 | 2021-08-03 |
| Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis metformin 500 mg TID Oral Tablet, Placebo - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Unknown | National Hepatology & Tropical Medicine Research Institute | 40 | 2021-02-07 | 2021-02-11 |
| Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) AMT-101 (oral), Placebo (oral) - Ulcerative Colitis | Phase 2 | Unknown | Applied Molecular Transport | 105 | 2020-08-26 | 2022-11-07 |
| Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis Beta-1,3/1,6-D-Glucan, Placebo - Ulcerative Colitis | Phase 2 / Phase 3 | Unknown | Fakultas Kedokteran Universitas Indonesia | 204 | 2019-08-01 | 2019-08-02 |
| Outcomes Mandate National Integration With Cannabis as Medicine Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome | Phase 2 | Unknown | OMNI Medical Services, LLC | 200000 | 2018-12-01 | 2022-06-02 |
| Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients Fecal transplantation, Placebo - Ulcerative Colitis | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 100 | 2018-08-01 | 2018-07-11 |
| Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis Adipose-cord mesenchymal stromal cells (A-MSCs), Conventional drugs - Ulcerative Colitis (UC) | Phase 1 / Phase 2 | Unknown | Liaocheng People's Hospital | 50 | 2018-07-01 | 2020-09-02 |
| Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease Wharton Jelly Mesenchymal stem cells - Inflammatory Bowel Diseases | Phase 1 / Phase 2 | Unknown | Hanan Jafar | 20 | 2017-06-05 | 2019-04-10 |
| Fecal Microbiota Transplantation in Ulcerative Colitis Fecal transplantation - Ulcerative Colitis | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 100 | 2017-03-27 | 2017-09-06 |
| Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis Lactobacillus reuteri, Placebo - Ulcerative Colitis Flare | Phase 2 | Unknown | Uppsala University | 40 | 2017-01-01 | 2019-01-14 |
| Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis OPRX-106 - Ulcerative Colitis | Phase 2 | Unknown | Protalix | 20 | 2016-09-01 | 2016-09-28 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Fecal Microbiota Transplantation, Normal Saline - Ulcerative Colitis, Intestinal Bacteria Flora Disturbance | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Chengdu Medical College | 60 | 2016-07-01 | 2017-01-11 |
| The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Fecal Microbiota Transplantation - Ulcerative Colitis, Fecal Microbiota Transplantation | Phase 2 / Phase 3 | Unknown | Jun Liu | 20 | 2015-05-01 | 2015-05-06 |
Showing 20 of 34. Sign in to see all of them.
Colitis, Ulcerative (33) · Inflammatory Bowel Diseases (12) · Crohn Disease (7) · Diarrhea (2) · Abdominal Pain (1) · Acquired Immunodeficiency Syndrome (1) · Amyotrophic Lateral Sclerosis (1) · Anemia, Sickle Cell (1) · Anxiety Disorders (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Brain Injuries, Traumatic (1) · COVID-19 (1) · Chronic Pain (1)
Colonic Diseases (34) · Digestive System Diseases (34) · Gastroenteritis (34) · Gastrointestinal Diseases (34) · Intestinal Diseases (34) · Inflammatory Bowel Diseases (21) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Chemically-Induced Disorders (2) · Infections (2) · Mental Disorders (2) · Neurologic Manifestations (2) · Pain (2) · Pathologic Processes (2)
Fecal Microbiota Transplantation (5) · Mesalamine (2) · Saline Solution (2) · 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid (1) · Cell- and Tissue-Based Therapy (1) · Injections (1) · Medical Marijuana (1) · Metformin (1) · N-methyl-delta-3,3-dihydroindole-2,2 diketone (1) · Prednisolone (1) · Rosiglitazone (1) · Tablets (1) · ferric carboxymaltose (1) · nitazoxanide (1)
Assaf-Harofeh Medical Center (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Affiliated Hospital to Academy of Military Medical Sciences (1) · Altheus Therapeutics, Inc. (1) · Applied Molecular Transport (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · CannaMore Biotechs (1) · Curacle Co., Ltd. (1) · Dalia Lartey (1) · Fakultas Kedokteran Universitas Indonesia (1) · First Affiliated Hospital of Chengdu Medical College (1) · Hanan Jafar (1) · Herlev Hospital (1) · Instituto de Investigación Hospital Universitario La Paz (1)
China (6) · Israel (5) · United States (4) · Netherlands (3) · Canada (2) · France (2) · Germany (2) · Belarus (1) · Bulgaria (1) · Denmark (1) · Egypt (1) · Georgia (1) · Hungary (1) · India (1) · Indonesia (1)
Mark Lowenberg, MD PhD (2) · Bing Liu, M.D. (1) · Dongfeng Chen, doctor (1) · Dr. Ryan O Lakin, MD JD (1) · Einat Dekel, DVM (1) · Fergus Shanahan, Prof (1) · Fred Konikoff, professor (1) · Gang Zhao, MD (1) · Huijie Zhang, MD,PhD (1) · Longgui Wang, MD (1) · Marcellus Simadibrata (1) · Maria Dolores Martin Arranz, MD (1) · Max Karner, MD (1) · Min Min, M.D. (1)
PMID 23648372, PMID 24796768, PMID 26363929, PMID 30972640, PMID 31272391, PMID 32282545, PMID 32955197, PMID 33064186, PMID 33188747, PMID 33571293, PMID 35962454, PMID 39109266, PMID 39281978, PMID 40890737
2023 (2), 2008 (1), 2014 (1)